Symbol
LCTX on NYSE
Investment type
Equity - Shares of Stock
Class
Common Stock
Latest Disclosed Ownership
57.8M shares
Security Ownership
24.5%

NEAL C. BRADSHER ownership in Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

2025-01-28 - NEAL C. BRADSHER has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 57.8M shares of Lineage Cell Therapeutics, Inc. Common Stock (LCTX). This represents 24.5% percent ownership of the company.